ArticlePloS one2017

5-alpha-reductase inhibitor therapy postpones urine retention and prostate surgery in patients with prostate enlargement and a maximum uroflow rate of less than 15 ml/sec.

Wenhsu Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.